|
Volumn 19, Issue 9, 2005, Pages 1680-1681
|
Fusion of NUP214 to ABL1 on amplified episomes in T-ALL - Implications for treatment [6]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABELSON KINASE;
BCR ABL PROTEIN;
IMATINIB;
NUCLEAR PROTEIN;
PROTEIN NUP214;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
NUCLEOPORIN;
NUP214 PROTEIN, HUMAN;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADULT;
BONE MARROW TRANSPLANTATION;
CANCER INFILTRATION;
CANCER RELAPSE;
CASE REPORT;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENE AMPLIFICATION;
GENE FUSION;
HUMAN;
INTERPHASE;
KARYOTYPE;
LETTER;
MALE;
METAPHASE;
MOLECULAR PROBE;
PRIORITY JOURNAL;
T CELL LEUKEMIA;
GENETICS;
ONCOGENE;
PLASMID;
RECURRENT DISEASE;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ARTIFICIAL GENE FUSION;
GENE AMPLIFICATION;
GENES, ABL;
HUMANS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
LEUKEMIA, T-CELL, ACUTE;
MALE;
NUCLEAR PORE COMPLEX PROTEINS;
PIPERAZINES;
PLASMIDS;
PYRIMIDINES;
RECURRENCE;
|
EID: 26944431683
PISSN: 08876924
EISSN: 14765551
Source Type: Journal
DOI: 10.1038/sj.leu.2403877 Document Type: Letter |
Times cited : (25)
|
References (4)
|